Zydus Lifesciencesannounced that the Mexican regulatory authority COFEPRIS (Federal Commission for the Protection Against Sanitary Risk), has granted marketing approval for Bhava™, a Bevacizumab biosimilar.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
